_________________

._________________ .

60

13/12/07
 .1 72
:
.1
.2 Q 1V2V -
.3 T
.4 - ,ST QRS

IABP .2
.1
.2 PAWP
.3
.4 AFTERLOAD

.3
.1
COPD .2
.3
.4 1

.4 IABP:
+ Cardiac index-CI .1
Cardiac index-CI +Systemic vascular resistance-SVR .2
Wedge Pressure+ Systemic vascular resistance- SVR .3
SVR Systemic vascular resistance- + Mean arterial pressure- MAP .4

.5 CRT
VT .1
)CAVB .2 - (
) LVEF25% .3 (
.4 .
 .6 ?
B-BLOCKERS .1
Ca- BLOCKERS .2
.3
.4

.7 ,
.1
.2
.3 Preload
.4 After load

.8
20 .1
5 24 .2

.3
24 .4

.9 MR
.1
.2
.3
.4

.10
.1
.2
.3
.4
 . 11 " " ?
.1.
.2 .
.3 .
.4 .

.12 , 110/70 100

:
.1
.2
.3
.4

.13 :
.1
.2
.3
LDL <70 : .4

14
SYNCOPE .1
.2
.3
.4

.15 45 ST "
:
ca channel blocker .1
IIB/IIIA .2
.3
.4
 .16 72 4 , , ,
. ?
.1
.2
.3
VSD .4

.17 ?
.1
LM .2
4% .3
+ 50% .4

.18 50 5 ,
Q 5 ?
CPKMB .1
CPK .2
.3
.4

.19 60 ?
.1 ,ACE-I , ,
, , , .2
, ,ACE-I , .3
, ,anti-AT2 , .4
 .20 :
.1
IIBIIIA .2
.3
.4

. 21 -.. . ?
Depolarization- .1
p-r .2
QRS (QRS complex) - .3
repolarization - .4

. 22 , ,
:
Myoglobin .1.
Troponin I .2.
.3 .ST
.4 - .

.23 ) (4S :
.1 .
.2 ).(mitral
.3 ).(aortic
.4 ).(tricuspid

.24 dilated cardiomyopathy - :

.1 .
.2 .
.3.
.4
 . .25 - :
.1
.2 ACE
.3
.4

.26 ,acute coronary syndrome (ACS) - :

.1 C.P.K .
Troponin .2 , C.P.K , .
Myoglobin .3 , .
.4 Troponin 5 .

.27 , , 80/40" . : 3
. :
.1 .PEEP -
.2 Dopamine .
.3 Fusid .Isoket -
.4 .

.28 40% -
, :
.1 .Bretylium
.2 ).Amiodarone (procor
.3 ).Verapamil (IKACOR
.4 ).Propranolol (DERALIN
 .29 60 . .
:
left anterior descending artery .1
right coronary artery .2
proximal circumflex artery .3
distal posterior descending artery .4

.30 )(?
.1 I
.2
.3
.4 ' .

.31 , -.. :
.1 R + V5+V6 ST.V5+V6 -
.2 R + ST .
.3 ST + V1+V2 R .V6+V5 -
.4 R + V1+V2 - ST.V2+V1 -

.32 ?preload
.1 .
.2 .
.3 )).Pulmonary artery wedge pressure
.4 .

.33 :
.1
.2
.3
.4
 .34 :
)(acute MR .1
)(VSD .2
tamponade .3
)(aortic stenosis .4

.35 :
.1
.2
.3
.4

.36 - :
.1 5
.2
.3 20
.4

.37 " ST ACS:

T .1
ST .2
RBBB .3
LBBB .4

.38 :
, " .1
.2
.3
.4
 .39 :
.1 130-
.2 60-
.3
.4

.40
ST L1 AVL V5-V6 .1
ST V1-V4 .2
LBBB " .3
ST V1-V3 .4

.41
.1
.2
.3
.4

.42
.1
.2
: , .3
: ,, .4

.43 b blocker
.1
.2
.3
.4
 .44 ) (IABP
.1
.2
.3
.4

.45 DDDR
, , .1
, .2
, )(Over pacing .3
, .4

.46
.1
.2
.3
.4

.47 45 ,
, ,
,
.1
.2
.3
.4
 .48
.1
.2
.3
.4

.49
.1
.2
.3
.4

.50
.1
.2
.3
.4

.51
.1
.2
, .3
.4

.52
.1
.2
)(stroke volume .3
40% .4
 . 53
.1
.2
ACE .3
.4

.54. 10:30 , ST V3-

, V6

.1
.2
.3
.4

CRT-D .55
Cardiac Resynchronization Therapy with Defibrillator
.1
.2

/ , .3

. .4

.56
.1
.2
.3
.4

.57 "
.1
ST elevations diffuse .2
PR depression .3
 .4

.58
.1
.2
constrictive pericarditis .3
.4

.59 High output cardiac failure

afterload .1
- .2
, .3
.4

.60
.1
.2
.3
.4